Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Orphazyme A/S (ORPH)

0.87   0 (0%) 07-02 19:20
Open: 0.906 Pre. Close: 0.87
High: 0.955 Low: 0.8457
Volume: 941,412 Market Cap: 37(M)
Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company focuses on the amplification of heat-shock proteins to develop and commercialize therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including lysosomal storage and neuromuscular degenerative diseases. Its lead candidate is the Arimoclomol, which is in clinical development for four orphan diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, Inclusion Body Myositis, and Gaucher disease. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.96 - 0.96 0.96 - 0.97
Low: 0.83 - 0.84 0.84 - 0.84
Close: 0.86 - 0.87 0.87 - 0.88

Technical analysis

as of: 2022-07-01 4:24:13 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.06     One year: 1.11
Support: Support1: 0.84    Support2: 0.7
Resistance: Resistance1: 0.91    Resistance2: 0.95
Pivot: 0.87
Moving Average: MA(5): 0.87     MA(20): 0.87
MA(100): 0.78     MA(250): 2.61
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 22.2     %D(3): 22.2
RSI: RSI(14): 79.8
52-week: High: 7.13  Low: 0.1
Average Vol(K): 3-Month: 451 (K)  10-Days: 941 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ORPH ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 30 Jun 2022
Vaxart Announces Agreement with hVIVO to Develop World’s First Human Omicron Challenge Model - Yahoo Finance

Tue, 21 Jun 2022
Open Orphan delivering on growth expectations LON:ORPH - Preview - Proactive Investors USA

Wed, 15 Jun 2022
Open Orphan (LON:ORPH) Trading 2% Higher - Defense World

Mon, 13 Jun 2022
Parameter Hematology Analyzer Market Size, Growth And Forecast to 2028 |Orph e, Balio Diagnostics, Biosystems, Teco Diagnostics, Dymind – Designer Women - Designer Women

Tue, 07 Jun 2022
Here's Why Open Orphan (ORPH) Shares Plunged 10.6% on FY Results - AskTraders

Mon, 06 Jun 2022
Small Cap Feast - Brickability, Feedback, Open Orphan, and more... - Proactive Investors UK

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 35 (M)
% Held by Insiders 2.815e+007 (%)
% Held by Institutions 0 (%)
Shares Short 619 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -7.6223e+008
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -5
Return on Assets (ttm) 922.1
Return on Equity (ttm) -88.2
Qtrly Rev. Growth 1.315e+007
Gross Profit (p.s.) 0
Sales Per Share -335.12
EBITDA (p.s.) 0
Qtrly Earnings Growth -3.9
Operating Cash Flow 0 (M)
Levered Free Cash Flow -717 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 0.13

Stock Dividends

Dividend 0
Forward Dividend 104770
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.